BruceClaytonCorserMD, FAASM, MBA

Research • Cincinnati, OH

CEO/Owner sleep centers and clinical research facility

Join to view full profile

Dr. Corser is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Corser's full profile

Already have an account?

Office
5240 E Galbraith Rd
Ste A
Cincinnati, OH 45236
Phone+1 513-721-7533

Fax+1 513-721-1649

Education & Training

University of Cincinnati Medical Center/College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1984 - 1987
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1980 - 1983
SUNY Upstate Medical UniversityClass of 1980

Certifications & Licensure

KY State Medical License 1994 - 2025
OH State Medical License 1981 - 2025
IN State Medical License 2005 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease
American Board of Internal Medicine Sleep Medicine

Awards, Honors, & Recognition

Top Sleep Medicine Doctor in Ohio Top Doctor, 2020-2023

Clinical Trials

Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH Start of enrollment: 2022 Dec 28
Active, not recruiting
Phase 2
Roles: Contact
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen Start of enrollment: 2023 Mar 13
Recruiting
Phase 2
Roles: Contact

Publications & Presentations

PubMed

Atomoxetine and spironolactone combine to reduce obstructive sleep apnea severity and blood pressure in hypertensive patients.
Alan R Schwartz, Laura Herpel, Richard Bogan, Bruce Corser, Huy Pho
Sleep & Breathing = Schlaf & Atmung. 2024-12-01
15 citations
The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial.
Paula K Schweitzer, Luigi Taranto-Montemurro, Joseph M Ojile, Stephen G Thein, Christopher L Drake
American Journal of Respiratory and Critical Care Medicine. 2023-12-15